PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, 15784, Athens, Greece. itrougakos@biol.uoa.gr.\', \'Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528, Athens, Greece.\', \'Department of Animal and Human Physiology, Faculty of Biology, National and Kapodistrian University of Athens, 15784, Athens, Greece.\', \'Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, 11527, Athens, Greece.\', \'Human Retrovirus Section, National Cancer Institute, Frederick, MD, 21702, USA.\', \'Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 11528, Athens, Greece. mdimop@med.uoa.gr.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12929-020-00703-5
?:doi
?:hasPublicationType
?:journal
  • Journal of biomedical science
is ?:pmid of
?:pmid
?:pmid
  • 33435929
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.302
?:rankingScore_hIndex
  • 68
is ?:relation_isRelatedTo_publication of
?:title
  • Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all